1. Home
  2. ITRI vs DNLI Comparison

ITRI vs DNLI Comparison

Compare ITRI & DNLI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Itron Inc.

ITRI

Itron Inc.

HOLD

Current Price

$83.94

Market Cap

3.7B

Sector

Industrials

ML Signal

HOLD

Logo Denali Therapeutics Inc.

DNLI

Denali Therapeutics Inc.

HOLD

Current Price

$19.35

Market Cap

3.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ITRI
DNLI
Founded
1977
2013
Country
United States
United States
Employees
N/A
N/A
Industry
Electrical Products
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.7B
3.0B
IPO Year
1996
2017

Fundamental Metrics

Financial Performance
Metric
ITRI
DNLI
Price
$83.94
$19.35
Analyst Decision
Buy
Strong Buy
Analyst Count
11
14
Target Price
$129.00
$34.33
AVG Volume (30 Days)
607.6K
1.7M
Earning Date
04-28-2026
05-06-2026
Dividend Yield
N/A
N/A
EPS Growth
25.48
N/A
EPS
1.18
N/A
Revenue
$2,367,194,000.00
N/A
Revenue This Year
$4.64
N/A
Revenue Next Year
$6.62
$408.85
P/E Ratio
$71.86
N/A
Revenue Growth
N/A
N/A
52 Week Low
$77.77
$12.58
52 Week High
$142.00
$23.77

Technical Indicators

Market Signals
Indicator
ITRI
DNLI
Relative Strength Index (RSI) 48.32 47.86
Support Level $83.51 $18.27
Resistance Level $86.93 $20.65
Average True Range (ATR) 2.53 0.91
MACD 0.68 0.14
Stochastic Oscillator 65.67 47.26

Price Performance

Historical Comparison
ITRI
DNLI

About ITRI Itron Inc.

Itron Inc provides solutions that measure, manage, and analyze energy and water use. The company offers grid edge intelligence, energy and water management, smart city applications, Industrial Internet of Things (IIoT), and critical infrastructure and related services. It operates under the Itron brand and has four reportable segments: Device Solutions, Networked Solutions, Resiliency Solutions, and Outcomes. Key revenue is generated from the Networked Solutions segment, which includes a combination of communicating endpoints (e.g., smart meters, modules, endpoints, and sensors), network infrastructure, network design services, and associated headend management and application software designed and sold as a complete solution for acquiring and transporting robust application-specific data.

About DNLI Denali Therapeutics Inc.

Denali Therapeutics Inc is a biotechnology company that is engaged in developing and discovering therapeutics to defeat neurodegenerative diseases. The company's development programs include the LRRK2 Inhibitor Program, which develops brain penetrant small molecule LRRK2 inhibitor product candidates for Parkinson's disease. Its key products include DNL201, DNL151, ATV (Antibody Transport Vehicle), ETV (Enzyme Transport Vehicle), and others. The Company has one operating segment with the goal to discover, develop, and commercializing therapeutics.

Share on Social Networks: